DOSSIER · 13F Holders · Q4 2025
ENLIVEN THERAPEUTICS INC
5 institutions still hold ENLIVEN THERAPEUTICS INC as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 29337E106·5 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
5 institutions reported ENLIVEN THERAPEUTICS INC in Q4 2025. VR Adviser, LLC leads at 67.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.